1. What is the cash position with the company currently
2. What is the cash burn rate/month with current overheads
3. What would be revenue run rate vs cash burn rate by the end of the FY 2021. With anticipated 9 clinics opened by this year end.
4. What is the (realistic) anticipated revenue generation rate with Medisure ( relatively much easier to acalculate)and Kai labs( I understand will depend in covid situation and other external factors)
5. If the cash burn rate would be higher to revenue generation rate...what are the solutions to solve that problem or minimize the damage in short term. The reason I am asking is because if that solution is not thought out right now there would be dilution of the shares and that makes every retail shareholder nervous.